Financing type:  at-the-market prospectus offering

Gross proceeds:  $262,300 (Canadian) in the quarter ended June 30, 2025, on the TSX Venture Exchange; $10,990,442 (U.S.) in the quarter ended June 30, 2025, on the New York Stock Exchange

Offering:  115,874 common listed shares sold on the TSX-V; 6,393,216 common listed shares sold on the NYSE

Offering price:  an average price of $2.26 (Canadian) per listed share on the TSX-V; an average price of $1.72 (U.S.) per listed share on the NYSE

Disclosure:  Refer to the prospectus dated May 26, 2023, and July 26, 2023, as well as the prospectus supplement dated Nov. 15, 2023, and the company's news releases dated Nov. 17, 2023, April 12, 2024, July 5, 2024, Jan. 10, 2025, April 11, 2025, and July 4, 2025.